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Abstract
Background: Evidence on patient-reported outcomes of newly diagnosed HIV patients is scarce, and largely cross-
sectional. This prospective cohort study describes the prevalence of, and changes in, patient-reported outcomes in
the three months after HIV diagnosis, in 11 HIV outpatient centres in Kenya and Uganda.
Methods: Adults were recruited within 14 days of result, completing self-report measures four times at monthly
intervals. Multilevel mixed-effects linear regression (quality of life continuous outcomes) and ordinal logistic regression
(symptoms and concerns categorical outcomes) modelled change over time, with repeated observations grouped
within individuals adjusted for demographic/clinical characteristics, and multiple imputation for missing data.
Results: 438 adults were enrolled and 234 (53·4%) initiated ART. Improvement was found for MOS-HIV physical health
(from 46·3 [95% CI 45·1–47·3], to 53·7 [95% CI 52.8–54·6], p < 0.001), and mental health (from 46·4 [95% CI 45·5–47·3] to
54·5 [95% CI 53·7–55·4], p < 0.001). POS subscale ‘interpersonal problems’ improved but remained burdensome (OR =
0·91, 95% CI = 0·87–0·94, p < 0.001; 22·7% reported severe problems at final time point). The scores for the existential
POS subscale (OR = 0·95, 95% CI = 0.90–1·00, p = 0.056) and physical/psychological problems POS subscale (OR = 0·97,
95% CI = 0.92–1·02, p = 0.259) did not improve.
Participants who initiated ART had worsening physical/psychological (OR = 0·64, 95% CI = 0·41–0·99, p = 0·045) and
interpersonal problems (OR = 0·64, 95% CI = 0·42–0·96, p = 0·033).
Conclusion: Although some self-reported outcomes improve over time, burden of interpersonal problems remains
substantial and existential concerns do not improve.
Keywords: HIV, Newly diagnosed, Patient-report, Adjustment
Background
Increasing numbers of people will test HIV positive and
enter care due to efforts made to meet the UNAIDS 90–
90-90 targets of 90% of people with HIV in care, 90% of
those in care on antiretroviral therapy, and 90% of treated
patients virally suppressed [1]. In resource-constrained
settings where the HIV disease burden is greatest, health
systems and providers are under pressure, and a paradigm
shift is needed to enable an adequate, sustainable response
[2]. In order to achieve viral suppression, patients are re-
quired to adhere to ART and remain engaged with treat-
ment and care facilities. The current model of HIV care is
delivered in overstretched systems with weak infrastruc-
ture and high patient numbers, and these challenges have
been associated with attrition from ART programmes [3].
People recently diagnosed with HIV report physical
[4], psychological [5] and social support problems [6].
These problems have been identified by HIV outpatients
in East Africa as contributors to poor attendance and
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treatment adherence [7]. In a South African study of
people recently diagnosed with HIV, 14·8% met the cri-
teria for post-traumatic stress disorder, which is associ-
ated with worse functional health status [8]. This may
limit patients’ ability to absorb information and make
critical decisions about their care [9]. Conversely, the
phenomenon of post-traumatic growth has also been de-
scribed among people diagnosed with serious health
conditions, and the individual may report improved rela-
tionships, enhanced appreciation for life, and a greater
sense of personal strength [10].
A systematic review concluded that the lack of longi-
tudinal studies has prevented understanding of the indi-
vidual response to a HIV diagnosis over time, in terms
of quality of life, physical and psychosocial outcomes
[11]. A number of gaps were identified in the evidence,
principally: lack of measures of emotional support needs,
omission of spiritual distress, lack of studies that re-
cruited outpatients in low-income countries, use of staff
proxy rather than self-report, lack of measurement of
problems across domains, small sample sizes, lack of re-
peated measures to appraise adjustment to diagnosis,
and no longitudinal analysis methods.
Our cross-sectional analysis of 438 adults newly diag-
nosed with HIV (i.e. within 14 days) in 11 outpatient
centres in Kenya and Uganda reported the following
main problems: help and advice (64·7% scoring at the
worst end of the scale, i.e., 4–5 on a scale of 0–5); shar-
ing feelings (53·0%); spiritual distress (19·2%); feeling life
is not worthwhile (10·0%) [12]. For these problems and
additional measures of health-related quality of life, all
outcomes were independent of CD4 count or ART eligi-
bility. To retain these individuals in care, we must
understand how their problems change immediately fol-
lowing diagnosis so that responsive care can be planned.
The aim of this paper is to measure change in
patient-reported outcomes in the first three months fol-
lowing HIV diagnosis. The study objectives were to: i)
determine eligibility for ART at diagnosis and uptake in
the 3 months following diagnosis; ii) measure change in
patient-reported outcomes, iii) identify clinical and
demographic predictors of change.
Methods
Design
A secondary analysis was carried out on longitudinal
data from an observational cohort study conducted by
the authors as part of a mixed-methods evaluation of
care and support for the President’s Emergency Plan for
AIDS Relief (PEPFAR). The study protocol has previ-
ously been published [13]. The full cohort consisted of
approximately 120 adult HIV-positive outpatients from
each of 12 rural and urban health facilities in Kenya and
Uganda, enrolled in 2008 by consecutive sampling and
interviewed four times at monthly intervals [14]. The in-
clusion criteria were age 18 or over; aware of their HIV
diagnosis; and being new to care or presenting with a
new problem/symptom [13, 15]. Of these 1337 partici-
pants, those enrolled within 14 days following their HIV
diagnosis were selected for this secondary analysis.
Procedure
438 participants were enrolled within 14 days following
their HIV diagnosis at one of 11 clinical settings in
Kenya and Uganda (the twelfth had no newly diagnosed
patients), and were included in this analysis. Participants
were either diagnosed at the health facility where the
study was based, or diagnosed at a smaller health post/
mobile testing centre and referred to the recruiting facil-
ity for their HIV care.
Self-report data using validated patient-centred out-
come measures were collected at baseline and for 3 sub-
sequent monthly time points. The MOS-HIV (Medical
Outcomes Scale for HIV) is a widely used 35-item
health-related quality of life questionnaire [16] validated
in many countries including Uganda [17, 18]. Multidi-
mensional problems (physical, psychological, social and
spiritual) were measured using the APCA African Pallia-
tive Outcomes Scale (POS), designed and validated in
sub-Saharan Africa [19]. The POS is a 10-item Likert
questionnaire about multidimensional problems in the
previous 3 days, with each item scored 0–5. A demo-
graphic questionnaire was completed at baseline only,
and the date and results of a CD4 test (up to six months
after HIV diagnosis) and World Health Organization
(WHO) HIV stage were extracted from patients’ records.
Baseline data collection also included the ECOG, a
widely used single item measure of physical function
[20]. Questionnaires were translated from English into
Swahili, Luo, Luganda and Runyakitara, then piloted.
Analysis
Analysis was conducted using Stata v14.0. MOS-HIV
item scores were converted into continuous 0–100 sum-
mary scores for mental and physical health, with higher
scores indicating better health [17, 21]. The POS was
analysed using three previously validated factors: phys-
ical/psychological well-being, interpersonal well-being,
and existential well-being [22, 23]. Poverty quintile was
calculated in line with the DHS method using variables
including house construction, possession of items, and
fuel supply [24]. APCA African POS factors were cate-
gorised into mild/none (score 0–4), moderate problems
[5–7] and severe problems (≥8). The time variable was
defined as number of weeks since enrolment in care. In-
terviews were scheduled for one month apart but partic-
ipants frequently attended at longer intervals, so actual
time was used rather than number of visits. Visits more
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than 20 weeks after enrolment were excluded as outliers.
Multilevel mixed-effects linear regression with robust
standard errors was used to fit models for the subscale
continuous variables physical health score and mental
health score, with observations grouped within individ-
uals. For the ordinal POS factor variables, multilevel
mixed-effects ordinal logistic regression was used.
Co-variates were selected a priori and were either binary
(gender, ART initiation, country) or ordinal, fitted as
continuous (age category, physical function, poverty
quintile). ART initiation was defined as having initiated
ART during follow-up. To impute missing data we used
multiple imputation with 10 iterations on the same co-
variates plus baseline score, having set the data as
cross-sectional time series with individual ID to identify
the person and time since enrolment for the time.
Results
Sample characteristics
Baseline characteristics of the sample have been previ-
ously described in detail [12]. Of the 438 newly diag-
nosed participants, 270 (61·6%) were women, the age
range was 18–59 (mean 32·9); just over half (56·4%, n =
247) were enrolled in Kenya. Age distribution was 20·3%
aged 18–25, 63·0% aged 26–40 and 16·7% aged 41–59.
The majority (69·9%, n = 306) were physically fully active
(ECOG score 0), with 23·3% (n = 102) scoring 1 and
6·8% (n = 30) scoring more than 1. WHO stage was ob-
tained for 198 participants, with 26% Stage I, 36% Stage
II, 31% Stage III and 7% Stage IV.
Within 20 weeks, out of 438 participants, 52 (11·9%)
completed only one interview, 31 (7·1%) completed two,
33 (7·5%) completed three and 322 (73·5%) completed
all four (Fig. 1), making 1501 research data collection
visits out of a possible 1752 (85·7%). Out of 1501 visits,
438 were on the day of enrolment, by definition. 332
(22·1%) were 1–40 days after enrolment, 405 (27·0%) 41–
80 days after enrolment, 312 (20·8%) 81–120 days after
enrolment and 14 (0·9%) 121–242 days after enrolment.
Attendance and treatment
ART eligibility was not directly recorded at data collec-
tion so it was inferred later based on CD4 count and
WHO stage where these were available. In line with the
national guidelines in use at the time of data collection,
patients with a CD4 count below 350 cells/μl or a WHO
stage 4 were eligible for ART [25]. Patients with both
CD4 count ≥350 cells/μl and WHO stage 1–3 were not
eligible. Using these criteria, ART eligibility could be
established for 263/438 people (Table 1). 207 (78.7%)
were eligible for ART at enrolment (CD4 < 350 or WHO
stage 4). Out of 207 participants eligible for ART, 154
(74.4%) initiated ART within the study period and 53
(25·6%) did not. Of the 53 who did not initiate,16 only
attended one appointment at the facility and another 8
dropped out before completing all 4 appointments. For 5/53
who did not initiate ART, their CD4 test was delayed, so
their eligibility was not confirmed during follow-up. 21
people took ART at least once despite not being eligible ac-
cording to CD4 count and WHO stage. Out of 175 partici-
pants whose ART eligibility was unknown according to
available data on file, 59 initiated ART.
Change in patient-reported outcomes
Participants with fewer than 3 follow-up observations
had mean baseline physical and mental health scores 3
points lower than those of participants who had no
missing data, and were also more likely to report Exist-
ential problems.
At baseline, mean score on the physical health score of
the MOS-HIV was 46·3 (standard deviation 12.0). Men-
tal health score at baseline was 46·4 (standard deviation
9·9). A multi-level model with no covariates except for
Fig. 1 Number of participants per visit
Table 1 ART eligibility and initiation
Initiated ART n Never initiated n Total n
Eligible 154 53 207 (47·3%)
Not eligible 21 35 56 (12·8%)
Eligibility unknown 59 116 175 (40·0%)
Total 234 (53·4%) 204 (46·6%) 438 (100%)
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time showed that physical health score improved by 0.5
per week (95% CI 0·4–0·6) and mental health score by
0·6 per week (95% CI 0·5–0·6).
The prevalence of severe and moderate problems as
measured by the POS decreased over time for all subscales
(Fig. 2). However, interpersonal problems were the most
pervasive. Even after four clinic visits 74/326 (22·7%) par-
ticipants still reported severe interpersonal problems and
less than half (43·6%) reported mild/no problems.
After controlling for sociodemographic and health fac-
tors, on the MOS-HIV subscales, mental and physical
health scores both improved over time after recruitment
into care. On POS, Interpersonal problems subscale im-
proved over time. Existential problems improved, but
with only borderline significance (p = 0.056). No statisti-
cally significant improvement was found for the phys-
ical/psychological subscale.
Predictors of change on patient-reported outcomes
Limited physical function at baseline was associated with
worsening physical health score but improvement in the
interpersonal subscale (Table 2). Older age was associ-
ated with improvement in mental health score and exist-
ential problems over time. Gender was not associated
with any outcome.
Compared to the economically poorest, those with
greater wealth were likely to have improved physical and
mental health score and fewer physical/psychological or
existential problems over time. Compared to Kenya, par-
ticipants in Uganda had less improvement in physical or
mental health score over time, and more physical/psy-
chological and existential problems.
With respect to ART, initiation during the study
period was not associated with improvement in physical
or mental health scores or existential problems, but was
associated with improvement in both physical/psycho-
logical problems and interpersonal problems.
Discussion
This novel longitudinal multi-centred cohort study found
that, for adults newly diagnosed with HIV infection in
East Africa, statistically significant improvement was
found for both physical and mental health-related quality
of life (when controlling for patient characteristics). While
there was also improvement in interpersonal and existen-
tial problems, no statistically significant improvement was
found for physical/psychological problems.
This study has advanced the evidence by addressing
the conclusions of a systematic review which revealed an
absence of data to determine how people newly diag-
nosed with HIV change in their self-report health status
Fig. 2 Multidimensional problems and health-related quality of life over time
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over time [11]. This is timely, given the current policy to
greatly increase the proportion of people infected with
HIV who receive a test result, initiate therapy and re-
main in care to achieve viral suppression.
The association of POS scores and health-related qual-
ity of life outcomes with demographic variables at base-
line have been presented previously in a cross-sectional
study [12]. This study shows the association of variables
with change over time, adjusting for baseline values. In
the previous paper, the seven POS outcomes were ana-
lysed separately. Since then, factor analysis has deter-
mined the POS is composed of three factors [22], which
have been used as outcomes here.
Our descriptive analysis showed that the prevalence of
severe and moderate physical/psychological problems, as
measured by the POS, decreased over time. This associ-
ation, however, was no longer significant in the multi-
variate analysis after missing datapoints had been
imputed through multiple imputation. There was a rise
in prevalence of severe problems between the second
and third follow-up visits, which may have weakened the
association. Missingness was associated with lower base-
line scores for physical and mental health. Without mul-
tiple imputation, most findings were similar but physical
function was closely associated with all outcomes. The
likely explanation is that participants with poor physical
function were the most likely not to return.
Gender was not associated with any outcomes. In a
longitudinal study of 1274 people with HIV in Uganda,
women were at increased risk of poor mental health
score (if on ART) and poor physical health score (if not
initiated on ART) [26]. Depression was associated with
worse physical health score over time, whether patients
were on ART or not. There was no association between
change in CD4 count over time and physical or mental
health score [27], possibly because CD4 count was
relatively high at baseline (> 350 for 80% of participants),
or possibly because health scores reflect a more complex
state of quality of life that is not closely tied to immuno-
logical function.
The Kenya population had a lower CD4 count distri-
bution, although this is difficult to compare because al-
most half the Uganda sample did not have a CD4 count
in the dataset. This challenge in lack of CD4 count on
file has been previously reported [28], and is a concern
for the current policy of increasing the proportion of eli-
gible people on ART. The 11 sites varied in their settings,
services and populations. Notably, two of the Uganda sites
were TASO (The AIDS Support Organisation) centres,
which may offer a different balance of services.
Interestingly, ART was not associated with improve-
ment in physical health score over time, but there was
an association with the physical/psychological problems
and interpersonal problems subscales. This may reflect
the relatively brief time period, and also any improve-
ment in physical health due to viral suppression may
have been offset by initial treatment-related side effects.
It is important to note that while treatment did not in
the short term improve existential problems, it was asso-
ciated with improvement in interpersonal problems.
This is likely due to the increased communication re-
quired to begin and maintain treatment.
Our study confirms earlier findings that health-related
quality of life is worst at diagnosis and improves over
the next 6 months [29]. However, our study sample is
more representative of the population needing care than
the previous study, as it is selected from men and
women who registered at 11 sites after diagnosis through
VCT, antenatal testing or as a result of illness. The study
cited was of 160 women enrolled into a cohort while
HIV-uninfected, who were diagnosed in the acute infec-
tion stage.
Table 2 Mixed-effects models for multidimensional problems and health-related quality of life over time
physical health score mental health score APCA POS Physical/
psych. Problems
APCA POS
Interpersonal problems
APCA POS
Existential problems
Variable Reference group Coeff (95% CI) p Coeff (95% CI) p OR (95% CI) p OR 95% CI) p OR (95% CI) p
Week 0 0·28 (0·16,
0·40)
< 0·001 0·35 (0·25,
0·45)
< 0·001 0·97
(0·92, 1·02)
0·259 0·91
(0·87, 0.94)
< 0·001 0·95
(0·90, 1·00)
0·056
Physical
function
Fully active −8·69
(−10·18, −7·21)
< 0·001 −4·93
(−6·09, −3·76)
< 0·001 4·29
(2·94, 6·26)
< 0·001 0·86
(0·63, 1·19)
0·373 2·92
(1·89, 4.50)
< 0·001
Gender Male 0·81
(−0·48, 2·09)
0·218 0·23
(−1·11, 1·58)
0·733 1·22
(0·75, 2·00)
0·420 0·92
(0·59, 1·44)
0·717 0·69
(0·39, 1·23)
0·208
Age group 18–25 0·50
(−0·58, 1·59)
0·365 1·17 (0·03,
2·30)
0·045 1·28
(0·87, 1·87)
0·213 0·76
(0·54, 1·09)
0·133 0·65
(0·41, 1·03)
0·067
Poverty
quintile
Poorest 0·46
(0·04, 0·88)
0·033 0·38
(−0.05, 0·81)
0·082 0·76
(0·64, 0·91)
0·002 1·19
(1·02, 1·39)
0·031 0·88
(0·71, 1·07)
0·204
ART No ART 0·71
(−0·51, 1·92)
0·256 1.44
(0.11, 2.76)
0·033 0·51
(0·31, 0·82)
0·005 0·61
(0·39, 0·95)
0·028 0·86
(0·49, 1·52)
0·605
Country Kenya −0·98
(−2·19, 0·24)
0·114 −2·48
(−3·81, −1·15)
< 0·001 1·70
(1·07, 2·71)
0·026 1·01
(0·66, 1·55)
0·969 3·05
(1·72, 5·42)
< 0·001
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The trauma of an HIV diagnosis can affect social func-
tioning and mental health in addition to the implications
for physical health, which may be as a result of the
underlying infection or the psychosomatic impact of
knowledge of HIV status. In a study in South Africa, 55%
of people with HIV had depressive symptoms just before
their diagnosis [30]. Patients with depressive symptoms
are less likely to have a CD4 test or to return for the result,
which prevents or delays their entry into care [30]. We
have demonstrated that while mental-health related qual-
ity of life improves in the three months following diagno-
sis, interpersonal problems remain a great burden. This
reflects the highly stigmatised nature of living with HIV.
‘Interpersonal problems’ in the POS comprise two ques-
tions: ‘have you been able to share how you are feeling’
and ‘have you had enough help and advice for your family
to cope’. Non-disclosure of HIV status may have limited
participants’ opportunities to share feelings or provide
their family with the right help. The need for emotional
support has been shown to be a key motivator for disclos-
ure to family members [31].
Poorer physical function was predictive of a worse re-
sponse in physical health score and interpersonal prob-
lems. Given that late presentation with advanced disease
is still relatively common [4], those with poorer function
at diagnosis will require greater attention to achieve
benefit from entering care and improvements in
self-report wellbeing, and should be considered at in-
creased risk. The finding may also reflect added barriers
for people with disabilities [32].
In low- and middle-income countries, depression and
other mental, neurological and substance use disorders
are common among people living with HIV but diagno-
sis and treatment remains poor [33]. HIV service pro-
viders lack confidence and understanding of mental
health care [34, 35]. There is growing evidence that ra-
ther than being a task for specialist referral, lay health
workers can be trained to manage common mental dis-
orders in a primary care setting [36, 37], including care
for people with HIV [38].
There are a number of limitations to our study. The
cohort length of three months is relatively short, but it
covers the crucial period immediately after diagnosis
when decisions about care must be made and habits of
adherence established [9]. CD4 count was missing from
half the sample, almost entirely in Uganda, which, indi-
cates non-random programmatic variation [28]. CD4
was not included in the multilevel models as it would
have skewed the sample as well as reducing the sample
size, which was already relatively small. Many variables
that could affect multidimensional problems or quality
of life were not collected and so could not be adjusted
for. We note that poorer health-related quality of life
and poorer mental health are associated with attrition
from care [39], and therefore there is a risk of attrition bias
in our sample which would cause outcomes to appear to
improve over time. While the use of patient-reported out-
comes is a strength of this study, patient-reported clinical
details may be a limitation. ART data is patient-reported
and clinically assessed ART eligibility was not recorded.
We used consecutive sampling, which is non-probabilistic
and can be biased, although it is more representative than
most other convenience methods.
Conclusions
Our study has revealed that while improvements in
patient-reported outcomes are experienced in the three
months following HIV diagnosis, a high burden persists,
particularly for psychosocial problems. The benefits of
entering care are associated with socio-demographic
characteristics such as country, age and poverty. The
WHO definition of health, established in 1948, remains
relevant: physical, psychological and social wellbeing
[40]. Low-cost approaches to person-centred care should
be considered for people on ART, especially given the
highest burden of interpersonal problems [41]. While ac-
cess to testing, treatment and care is expanding under
current policy, it is important that the psychosocial as-
pect of HIV disease is not ignored [42].
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